Background: Traditionally believed to be an integral part of multiple myeloma (MM) treatment. the role of hematopoietic stem-cell transplantation (HSCT) is being challenged. As such. we sought to evaluate the impact of HSCT in the era of novel agents. https://www.markymarkscott.com/product-category/processing-solution/